Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa

NCT03068780 is registered in ClinicalTrials.gov with Amryt Research Limited as lead sponsor.

NCT NCT03068780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03068780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow-up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa
Lead sponsor
Amryt Research Limited
Phase
Phase 3
Overall status
Completed
Start date
March 29, 2017
Completion date
May 27, 2022
Enrollment
223 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

epidermolysis bullosa